Investigation of Peptidoglycan-Associated Lipoprotein of Acinetobacter baumannii and Its Interaction with Fibronectin To Find Its Therapeutic Potential
暂无分享,去创建一个
[1] Vishvanath Tiwari,et al. Potentiate the activity of current antibiotics by naringin dihydrochalcone targeting the AdeABC efflux pump of multidrug-resistant Acinetobacter baumannii. , 2022, International journal of biological macromolecules.
[2] S. McClean,et al. Mapping Global Prevalence of Acinetobacter baumannii and Recent Vaccine Development to Tackle It , 2021, Vaccines.
[3] C. Cluzel,et al. Incidence of an intracellular multiplication niche amongst Acinetobacter baumannii clinical isolates , 2021, bioRxiv.
[4] Vandana Solanki,et al. Immunoinformatic approach to design a multiepitope vaccine targeting non-mutational hotspot regions of structural and non-structural proteins of the SARS CoV2 , 2021, PeerJ.
[5] I. Kyriakidis,et al. Acinetobacter baumannii Antibiotic Resistance Mechanisms , 2021, Pathogens.
[6] Quentin J. Leclerc,et al. Antimicrobial resistance and COVID-19: Intersections and implications , 2021, eLife.
[7] Vandana Solanki,et al. Subtractive Proteomics and Reverse Vaccinology Strategies for Designing a Multiepitope Vaccine Targeting Membrane Proteins of Klebsiella pneumoniae , 2021, International Journal of Peptide Research and Therapeutics.
[8] Vishvanath Tiwari. Denovo designing, retro-combinatorial synthesis, and molecular dynamics analysis identify novel antiviral VTRM1.1 against RNA-dependent RNA polymerase of SARS CoV2 virus , 2021, International Journal of Biological Macromolecules.
[9] G. Wilharm,et al. Novel Genes Required for Surface-Associated Motility in Acinetobacter baumannii , 2020, Current Microbiology.
[10] Vandana Solanki,et al. Subtractive proteomic analysis of antigenic extracellular proteins and design a multi‐epitope vaccine against Staphylococcus aureus , 2020, Microbiology and immunology.
[11] Patrick S. Gellings,et al. Recent Advances in the Pursuit of an Effective Acinetobacter baumannii Vaccine , 2020, Pathogens.
[12] W. Lima,et al. Ventilator-associated pneumonia (VAP) caused by carbapenem-resistant Acinetobacter baumannii in patients with COVID-19: Two problems, one solution? , 2020, Medical Hypotheses.
[13] C. Kleanthous,et al. The multifarious roles of Tol-Pal in Gram-negative bacteria , 2020, FEMS microbiology reviews.
[14] B. Zhu,et al. Co-infection with respiratory pathogens among COVID-2019 cases , 2020, Virus Research.
[15] Vishvanath Tiwari,et al. Rational targeting of Wzb phosphatase and Wzc kinase interaction inhibits extracellular polysaccharides synthesis and biofilm formation in Acinetobacter baumannii. , 2020, Carbohydrate research.
[16] C. Ayoub Moubareck,et al. Insights into Acinetobacter baumannii: A Review of Microbiological, Virulence, and Resistance Traits in a Threatening Nosocomial Pathogen , 2020, Antibiotics.
[17] Seungwoo Hwang,et al. IL-10 Protects Mice From the Lung Infection of Acinetobacter baumannii and Contributes to Bacterial Clearance by Regulating STAT3-Mediated MARCO Expression in Macrophages , 2020, Frontiers in Immunology.
[18] B. He,et al. The Peptidoglycan-associated lipoprotein Pal contributes to the virulence of Burkholderia mallei and provides protection against lethal aerosol challenge , 2020, Virulence.
[19] B. Dam,et al. Adaptation of ethidium bromide fluorescence assay to monitor activity of efflux pumps in bacterial pure cultures or mixed population from environmental samples , 2020 .
[20] J. Malmström,et al. Interaction with the host: the role of fibronectin and extracellular matrix proteins in the adhesion of Gram-negative bacteria , 2019, Medical Microbiology and Immunology.
[21] Q. Zou,et al. DNA vaccine encoding OmpA and Pal from Acinetobacter baumannii efficiently protects mice against pulmonary infection , 2019, Molecular Biology Reports.
[22] R. Shapouri,et al. Virulence characteristics of multidrug resistant biofilm forming Acinetobacter baumannii isolated from intensive care unit patients , 2019, BMC Infectious Diseases.
[23] A. Peleg,et al. The Mechanisms of Disease Caused by Acinetobacter baumannii , 2019, Front. Microbiol..
[24] V. Müller,et al. Coping with low water activities and osmotic stress in Acinetobacter baumannii: significance, current status and perspectives. , 2019, Environmental microbiology.
[25] G. Asokan,et al. WHO Global Priority Pathogens List: A Bibliometric Analysis of Medline-PubMed for Knowledge Mobilization to Infection Prevention and Control Practices in Bahrain , 2019, Oman medical journal.
[26] Vandana Solanki,et al. Prioritization of potential vaccine targets using comparative proteomics and designing of the chimeric multi-epitope vaccine against Pseudomonas aeruginosa , 2019, Scientific Reports.
[27] I. Biswas,et al. In Vitro Motility Assays for Acinetobacter Species. , 2019, Methods in molecular biology.
[28] Maricarmen Íñiguez-Moreno,et al. Biofilm Formation by Staphylococcus aureus Isolated from Food Contact Surfaces in the Dairy Industry of Jalisco, Mexico , 2018, Journal of Food Quality.
[29] M. Paulsson,et al. How bacteria hack the matrix and dodge the bullets of immunity , 2018, European Respiratory Review.
[30] Vishvanath Tiwari,et al. Targeting Outer Membrane Protein Component AdeC for the Discovery of Efflux Pump Inhibitor against AdeABC Efflux Pump of Multidrug Resistant Acinetobacter baumannii , 2018, Cell Biochemistry and Biophysics.
[31] Vandana Solanki,et al. Subtractive proteomics to identify novel drug targets and reverse vaccinology for the development of chimeric vaccine against Acinetobacter baumannii , 2018, Scientific Reports.
[32] D. Alsteens,et al. Mechanical Forces Guiding Staphylococcus aureus Cellular Invasion. , 2018, ACS nano.
[33] F. Yuan,et al. Binding of Fibronectin to SsPepO Facilitates the Development of Streptococcus suis Meningitis , 2018, The Journal of infectious diseases.
[34] Vishvanath Tiwari,et al. Rationale and design of an inhibitor of RecA protein as an inhibitor of Acinetobacter baumannii , 2018, The Journal of Antibiotics.
[35] Vishvanath Tiwari,et al. In-silico screening and experimental validation reveal L-Adrenaline as anti-biofilm molecule against biofilm-associated protein (Bap) producing Acinetobacter baumannii. , 2018, International journal of biological macromolecules.
[36] M. Feldman,et al. Uncovering the mechanisms of Acinetobacter baumannii virulence , 2017, Nature Reviews Microbiology.
[37] G. Donelli,et al. Strategies for combating bacterial biofilms: A focus on anti-biofilm agents and their mechanisms of action , 2017, Virulence.
[38] Vandana Solanki,et al. Polyvinylpyrrolidone-Capped Silver Nanoparticle Inhibits Infection of Carbapenem-Resistant Strain of Acinetobacter baumannii in the Human Pulmonary Epithelial Cell , 2017, Front. Immunol..
[39] R. Berisio,et al. The Burkholderia cenocepacia peptidoglycan‐associated lipoprotein is involved in epithelial cell attachment and elicitation of inflammation , 2017, Cellular microbiology.
[40] Chien-Cheng Chen,et al. The expression of fibronectin is significantly suppressed in macrophages to exert a protective effect against Staphylococcus aureus infection , 2017, BMC Microbiology.
[41] Jung Hun Lee,et al. Biology of Acinetobacter baumannii: Pathogenesis, Antibiotic Resistance Mechanisms, and Prospective Treatment Options , 2017, Front. Cell. Infect. Microbiol..
[42] P. Rather,et al. An ompR-envZ Two-Component System Ortholog Regulates Phase Variation, Osmotic Tolerance, Motility, and Virulence in Acinetobacter baumannii Strain AB5075 , 2016, Journal of bacteriology.
[43] R. Bonomo,et al. Clinical and Pathophysiological Overview of Acinetobacter Infections: a Century of Challenges , 2016, Clinical Microbiology Reviews.
[44] Syma Khalid,et al. OmpA: A Flexible Clamp for Bacterial Cell Wall Attachment. , 2016, Structure.
[45] Alexandre M. J. J. Bonvin,et al. PRODIGY: a web server for predicting the binding affinity of protein-protein complexes , 2016, Bioinform..
[46] H. H. Low,et al. Membrane remodelling in bacteria. , 2016, Journal of structural biology.
[47] T. Foster,et al. The remarkably multifunctional fibronectin binding proteins of Staphylococcus aureus , 2016, European Journal of Clinical Microbiology and Infectious Diseases.
[48] L. Visai,et al. Allosteric Regulation of Fibronectin/α5β1 Interaction by Fibronectin-Binding MSCRAMMs , 2016, PloS one.
[49] H. Yin,et al. Drugging Membrane Protein Interactions. , 2016, Annual review of biomedical engineering.
[50] Vishvanath Tiwari,et al. Screening of Herbal-Based Bioactive Extract Against Carbapenem-Resistant Strain of Acinetobacter baumannii. , 2016, Microbial drug resistance.
[51] I. Biswas,et al. Biofilm Formation and Motility Depend on the Nature of the Acinetobacter baumannii Clinical Isolates , 2016, Front. Public Health.
[52] Brian T. Tsuji,et al. Colistin and Polymyxin B Dosage Regimens against Acinetobacter baumannii: Differences in Activity and the Emergence of Resistance , 2016, Antimicrobial Agents and Chemotherapy.
[53] Yusen Liu,et al. KatG and KatE confer Acinetobacter resistance to hydrogen peroxide but sensitize bacteria to killing by phagocytic respiratory burst. , 2016, Life sciences.
[54] J. Valle,et al. Analysis of the role of the LH92_11085 gene of a biofilm hyper-producing Acinetobacter baumannii strain on biofilm formation and attachment to eukaryotic cells , 2016, Virulence.
[55] Weiwei Huang,et al. Immunization with a 22-kDa outer membrane protein elicits protective immunity to multidrug-resistant Acinetobacter baumannii , 2016, Scientific Reports.
[56] A. M. González-Villoria,et al. Antibiotic-Resistant Acinetobacter baumannii Increasing Success Remains a Challenge as a Nosocomial Pathogen , 2016, Journal of pathogens.
[57] Medhat A. Haroun,et al. Development of immunization trials against Acinetobacter baumannii , 2016 .
[58] I. Rasooli,et al. Immunogenicity of conserved cork and β-barrel domains of baumannii acinetobactin utilization protein in an animal model. , 2015, Turkish journal of medical sciences.
[59] Devin K Schweppe,et al. Host-Microbe Protein Interactions during Bacterial Infection. , 2015, Chemistry & biology.
[60] Weiwei Huang,et al. OmpW is a potential target for eliciting protective immunity against Acinetobacter baumannii infections. , 2015, Vaccine.
[61] H. Hayden,et al. Resources for Genetic and Genomic Analysis of Emerging Pathogen Acinetobacter baumannii , 2015, Journal of bacteriology.
[62] Ming-Hsien Chiang,et al. Identification of novel vaccine candidates against Acinetobacter baumannii using reverse vaccinology , 2015, Human vaccines & immunotherapeutics.
[63] M. McConnell,et al. Immunization with Lipopolysaccharide-Deficient Whole Cells Provides Protective Immunity in an Experimental Mouse Model of Acinetobacter baumannii Infection , 2014, PloS one.
[64] A. Hartke,et al. Identification of Peptidoglycan-Associated Proteins as Vaccine Candidates for Enterococcal Infections , 2014, PloS one.
[65] Bin Chen,et al. Immunization against Multidrug-Resistant Acinetobacter baumannii Effectively Protects Mice in both Pneumonia and Sepsis Models , 2014, PloS one.
[66] Vishvanath Tiwari,et al. Conformational stability of OXA-51 β-lactamase explains its role in carbapenem resistance of Acinetobacter baumannii , 2014, Journal of biomolecular structure & dynamics.
[67] A. Gamian,et al. Enolase-like protein present on the outer membrane of Pseudomonas aeruginosa binds plasminogen , 2014, Folia Microbiologica.
[68] J. Pachón,et al. Association of the outer membrane protein Omp33 with fitness and virulence of Acinetobacter baumannii. , 2013, The Journal of infectious diseases.
[69] K. Seidl,et al. The MTT assay is a rapid and reliable quantitative method to assess Staphylococcus aureus induced endothelial cell damage. , 2013, Journal of microbiological methods.
[70] Rui Zhou,et al. A novel fibronectin-binding protein of Streptococcus suis serotype 2 contributes to epithelial cell invasion and in vivo dissemination. , 2013, Veterinary microbiology.
[71] Nicole R. Luke-Marshall,et al. The K1 Capsular Polysaccharide from Acinetobacter baumannii Is a Potential Therapeutic Target via Passive Immunization , 2013, Infection and Immunity.
[72] E. Marcotte,et al. Role of Pseudomonas aeruginosa Peptidoglycan-Associated Outer Membrane Proteins in Vesicle Formation , 2012, Journal of bacteriology.
[73] J. Boyce,et al. Lipopolysaccharide-Deficient Acinetobacter baumannii Shows Altered Signaling through Host Toll-Like Receptors and Increased Susceptibility to the Host Antimicrobial Peptide LL-37 , 2012, Infection and Immunity.
[74] L. Burrows. Pseudomonas aeruginosa twitching motility: type IV pili in action. , 2012, Annual review of microbiology.
[75] A. Kapil,et al. Carbapenem-hydrolyzing oxacillinase in high resistant strains of Acinetobacter baumannii isolated from India. , 2012, Microbial pathogenesis.
[76] A. Kapil,et al. Comparative Proteomics of Inner Membrane Fraction from Carbapenem-Resistant Acinetobacter baumannii with a Reference Strain , 2012, PloS one.
[77] R. López-Rojas,et al. Platelet-activating Factor Receptor Initiates Contact of Acinetobacter baumannii Expressing Phosphorylcholine with Host Cells , 2012, The Journal of Biological Chemistry.
[78] G. Pier,et al. Identification of Ata, a Multifunctional Trimeric Autotransporter of Acinetobacter baumannii , 2012, Journal of bacteriology.
[79] W. Haskins,et al. Association of Acinetobacter baumannii EF-Tu with Cell Surface, Outer Membrane Vesicles, and Fibronectin , 2012, TheScientificWorldJournal.
[80] M. McConnell,et al. Role of Fibronectin in the Adhesion of Acinetobacter baumannii to Host Cells , 2012, PloS one.
[81] M. Adams,et al. Active and Passive Immunization Protects against Lethal, Extreme Drug Resistant-Acinetobacter baumannii Infection , 2012, PloS one.
[82] J. Boyce,et al. Colistin-Resistant, Lipopolysaccharide-Deficient Acinetobacter baumannii Responds to Lipopolysaccharide Loss through Increased Expression of Genes Involved in the Synthesis and Transport of Lipoproteins, Phospholipids, and Poly-β-1,6-N-Acetylglucosamine , 2011, Antimicrobial Agents and Chemotherapy.
[83] T. Arimoto,et al. Surface Lipoprotein PpiA of Streptococcus mutans Suppresses Scavenger Receptor MARCO-Dependent Phagocytosis by Macrophages , 2011, Infection and Immunity.
[84] R. Coral-Vázquez,et al. Innate response of human endothelial cells infected with mycobacteria. , 2011, Immunobiology.
[85] T. Foster,et al. Fibrinogen Is a Ligand for the Staphylococcus aureus Microbial Surface Components Recognizing Adhesive Matrix Molecules (MSCRAMM) Bone Sialoprotein-binding Protein (Bbp) , 2011, The Journal of Biological Chemistry.
[86] Y. Mizunoe,et al. Role of Fibronectin-Binding Proteins A and B in In Vitro Cellular Infections and In Vivo Septic Infections by Staphylococcus aureus , 2011, Infection and Immunity.
[87] M. McConnell,et al. Active and passive immunization against Acinetobacter baumannii using an inactivated whole cell vaccine. , 2010, Vaccine.
[88] Ruth Nussinov,et al. An integrated suite of fast docking algorithms , 2010, Proteins.
[89] R. López-Rojas,et al. Vaccination with Outer Membrane Complexes Elicits Rapid Protective Immunity to Multidrug-Resistant Acinetobacter baumannii , 2010, Infection and Immunity.
[90] Yongqun He,et al. Vaxign: The First Web-Based Vaccine Design Program for Reverse Vaccinology and Applications for Vaccine Development , 2010, Journal of biomedicine & biotechnology.
[91] Martin Ester,et al. PSORTb 3.0: improved protein subcellular localization prediction with refined localization subcategories and predictive capabilities for all prokaryotes , 2010, Bioinform..
[92] Massimo Bernaschi,et al. Computational Immunology Meets Bioinformatics: The Use of Prediction Tools for Molecular Binding in the Simulation of the Immune System , 2010, PloS one.
[93] J. Johansson,et al. The extracellular domain of Bri2 (ITM2B) binds the ABri peptide (1-23) and amyloid beta-peptide (Abeta1-40): Implications for Bri2 effects on processing of amyloid precursor protein and Abeta aggregation. , 2010, Biochemical and biophysical research communications.
[94] M. Kempf,et al. The virulence variability of different Acinetobacter baumannii strains in experimental pneumonia. , 2010, The Journal of infection.
[95] Chul Hee Choi,et al. Serum resistance of Acinetobacter baumannii through the binding of factor H to outer membrane proteins. , 2009, FEMS microbiology letters.
[96] E. K. Jagusztyn-Krynicka,et al. Peptidoglycan-associated lipoprotein (Pal) of Gram-negative bacteria: function, structure, role in pathogenesis and potential application in immunoprophylaxis. , 2009, FEMS microbiology letters.
[97] T. Weisbrod,et al. Protection of Mycobacterium tuberculosis from Reactive Oxygen Species Conferred by the mel2 Locus Impacts Persistence and Dissemination , 2009, Infection and Immunity.
[98] J. Gaddy,et al. Regulation of Acinetobacter baumannii biofilm formation. , 2009, Future microbiology.
[99] Chul Hee Choi,et al. Acinetobacter baumannii invades epithelial cells and outer membrane protein A mediates interactions with epithelial cells , 2008, BMC Microbiology.
[100] Hyuk Chu,et al. Fibronectin facilitates the invasion of Orientia tsutsugamushi into host cells through interaction with a 56-kDa type-specific antigen. , 2008, The Journal of infectious diseases.
[101] Chul Hee Choi,et al. Acinetobacter baumannii outer membrane protein A targets the nucleus and induces cytotoxicity , 2007, Cellular microbiology.
[102] Nichollas E. Scott,et al. Identification of membrane‐associated proteins from Campylobacter jejuni strains using complementary proteomics technologies , 2008, Proteomics.
[103] Weiyuan John Kao,et al. The interrelated role of fibronectin and interleukin-1 in biomaterial-modulated macrophage function. , 2007, Biomaterials.
[104] T. Murphy,et al. Construction of a Mutant and Characterization of the Role of the Vaccine Antigen P6 in Outer Membrane Integrity of Nontypeable Haemophilus influenzae , 2006, Infection and Immunity.
[105] Jenn-Kang Hwang,et al. Prediction of protein subcellular localization , 2006, Proteins.
[106] Christof R Hauck,et al. Sticky connections: extracellular matrix protein recognition and integrin-mediated cellular invasion by Staphylococcus aureus. , 2006, Current opinion in microbiology.
[107] S. Hartson,et al. Adherence of Pasteurella multocida to fibronectin. , 2005, Veterinary microbiology.
[108] Ruth Nussinov,et al. PatchDock and SymmDock: servers for rigid and symmetric docking , 2005, Nucleic Acids Res..
[109] Jun Yu,et al. VFDB: a reference database for bacterial virulence factors , 2004, Nucleic Acids Res..
[110] D. Wiley,et al. Structure of the human class I histocompatibility antigen, HLA-A2. , 2005, Journal of immunology.
[111] J. Potts,et al. The molecular basis of fibronectin‐mediated bacterial adherence to host cells , 2004, Molecular microbiology.
[112] G. Wyatt,et al. A comparison of the traditional method of counting viable cells and a quick microplate method for monitoring the growth characteristics of Listeria monocytogenes , 2004, Letters in applied microbiology.
[113] A. Yamaguchi,et al. Membrane topology of ABC‐type macrolide antibiotic exporter MacB in Escherichia coli , 2003, FEBS letters.
[114] K. Kim,et al. Fibronectin mediates Opc‐dependent internalization of Neisseria meningitidis in human brain microvascular endothelial cells , 2002, Molecular microbiology.
[115] Link,et al. UvA-DARE ( Digital Academic Repository ) Identification of virulence factors of Streptococcus suis , 2011 .
[116] A. Krogh,et al. Predicting transmembrane protein topology with a hidden Markov model: application to complete genomes. , 2001, Journal of molecular biology.
[117] S. Johansson,et al. Cellular invasion by Staphylococcus aureus involves a fibronectin bridge between the bacterial fibronectin-binding MSCRAMMs and host cell beta1 integrins. , 2000, European journal of cell biology.
[118] J. Chia,et al. Identification of a Fibronectin Binding Protein from Streptococcus mutans , 2000, Infection and Immunity.
[119] R D Appel,et al. Protein identification and analysis tools in the ExPASy server. , 1999, Methods in molecular biology.
[120] A. Koide,et al. The fibronectin type III domain as a scaffold for novel binding proteins. , 1998, Journal of molecular biology.
[121] M. A. Saper,et al. Structure of the human class I histocompatibility antigen, HLA-A2 , 1987, Nature.